CIRM Funded Clinical Trials

A Phase I/IIa Study to Evaluate the Efficacy of Toca 511/Toca FC with Standard of Care Therapy in Newly Diagnosed High Grade Glioma

Disease Area:
CIRM Grant:
CLIN2-15311 (Pre-Active)
Award Value:
Trial Sponsor:
University of California, San Francisco
Trial Stage:
Phase 1
Trial Status:
Targeted Enrollment:

CIRM Clinical Trial Resources

Patient Stories of Hope

CIRM Alpha Stem Cell Clinics

Patient Toolbox

Video on Stem Cell Trials

Other Resources

ISSCR Patient Website